Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Atricure Inc (ATRC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 606,327
  • Shares Outstanding, K 34,470
  • Annual Sales, $ 155,110 K
  • Annual Income, $ -33,340 K
  • 36-Month Beta 0.66
  • Price/Sales 3.33
  • Price/Cash Flow N/A
  • Price/Book 3.80

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.43 +0.98%
on 01/18/18
18.95 -7.12%
on 01/03/18
-0.74 (-4.03%)
since 12/19/17
3-Month
16.18 +8.78%
on 12/12/17
23.34 -24.59%
on 10/20/17
-5.30 (-23.14%)
since 10/19/17
52-Week
14.78 +19.08%
on 01/23/17
25.18 -30.10%
on 07/31/17
+2.37 (+15.56%)
since 01/19/17

Most Recent Stories

More News
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2017

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced preliminary financial...

ATRC : 17.60 (+0.06%)
AtriCure to Present at the 36th Annual JP Morgan Healthcare Conference

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it...

ATRC : 17.60 (+0.06%)
AtriCure to Present at the Piper Jaffray 29th Annual Healthcare Conference

AtriCure, Inc. (Nasdaq:ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will...

ATRC : 17.60 (+0.06%)
AtriCure Reports Third Quarter 2017 Financial Results

--U.S. revenue of $33.4 million - an increase of 9.2% year over year

ATRC : 17.60 (+0.06%)
AtriCure to Present at the Stifel Healthcare Conference

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it...

ATRC : 17.60 (+0.06%)
AtriCure to Announce Third Quarter 2017 Financial Results

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release...

ATRC : 17.60 (+0.06%)
AtriCure to Present at the Morgan Stanley Global Healthcare Conference

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it...

MS : 57.46 (+2.90%)
ATRC : 17.60 (+0.06%)
Shares of Atricure Inc Rank the Highest in Terms of Relative Performance in the Health Care Equipment Industry (ATRC, SYK, ABMD, IDXX, ISRG)

We looked at the Health Care Equipment industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We...

SYK : 161.28 (+0.62%)
ABMD : 228.29 (+1.06%)
IDXX : 180.63 (+0.91%)
ATRC : 17.60 (+0.06%)
ISRG : 433.23 (+0.27%)
AtriCure Reports Second Quarter 2017 Financial Results

--U.S. revenue of $35.5 million - an increase of 15.1% year over year

ATRC : 17.60 (+0.06%)
AtriCure to Present at the Canaccord Genuity 37th Annual Growth Conference

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it...

ATRC : 17.60 (+0.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Business Summary

AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as...

See More

Key Turning Points

2nd Resistance Point 18.01
1st Resistance Point 17.81
Last Price 17.60
1st Support Level 17.42
2nd Support Level 17.23

See More

52-Week High 25.18
Fibonacci 61.8% 21.21
Fibonacci 50% 19.98
Fibonacci 38.2% 18.75
Last Price 17.60
52-Week Low 14.78

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.